Výsledky vyhledávání - "Yann, Bouvet"

Akademický článek

Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain

Autor: Christine Vala, Céline Mothes, Gabrielle Chicheri, Pauline Magadur, Gilles Viot, Jean-Bernard Deloye, Serge Maia, Yann Bouvet, Anne-Claire Dupont, Nicolas Arlicot, Denis Guilloteau, Patrick Emond, Johnny Vercouillie

Publikováno v: EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-14 (2020)

Abstract Background Fluorine labelled 8-((E)-4-fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid methyl ester ([18F]LBT999) is a selective radioligand for the in vivo neuroimaging and quantification of the dopamine transpo

Externí odkaz: https://doaj.org/article/cc76bd2c9b0b41288b696111b1292997

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

Autor: Elodie Jouberton, Sébastien Schmitt, Emmanuel Chautard, Aurélie Maisonial-Besset, Marie Roy, Nina Radosevic-Robin, Jean-Michel Chezal, Elisabeth Miot-Noirault, Yann Bouvet, Florent Cachin

Publikováno v: EJNMMI Research, Vol 10, Iss 1, Pp 1-14 (2020)

Abstract Purpose Pathological complete response to the neoadjuvant therapy (NAT) for triple negative breast cancer (TNBC) is predictive of prolonged patient survival. Methods for early evaluation of NAT efficiency are still needed, in order to rapidl

Externí odkaz: https://doaj.org/article/fb3d837ed0634f4f89e3c4ee3e01fb35

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model

Autor: Anis Krache, Charlotte Fontan, Carine Pestourie, Manuel Bardiès, Yann Bouvet, Pierre Payoux, Etienne Chatelut, Melanie White-Koning, Anne-Sophie Salabert

Publikováno v: Frontiers in Medicine, Vol 8 (2022)

Anti-PDL1 is a monoclonal antibody targeting the programmed death-cell ligand (PD-L1) by blocking the programmed death-cell (PD-1)/PD-L1 axis. It restores the immune system response in several tumours, such as non-small cell lung cancer (NSCLC). Anti

Externí odkaz: https://doaj.org/article/7e88c75dd0124f899fc8b11d3c6144fe

Zobrazit plný text záznamu

Preclinical Pharmacokinetics and Dosimetry of an

Autor: Anis, Krache, Charlotte, Fontan, Carine, Pestourie, Manuel, Bardiès, Yann, Bouvet, Pierre, Payoux, Etienne, Chatelut, Melanie, White-Koning, Anne-Sophie, Salabert

Publikováno v: Frontiers in medicine. 8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2bd25957c4b407a3d75996e0e4ff30ce
https://pubmed.ncbi.nlm.nih.gov/35174180

Zobrazit plný text záznamu

[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

Autor: Sébastien Schmitt, E. Jouberton, Marie Roy, Yann Bouvet, Aurélie Maisonial-Besset, Jean-Michel Chezal, Nina Radosevic-Robin, Elisabeth Miot-Noirault, Florent Cachin, Emmanuel Chautard

Publikováno v: EJNMMI Research
EJNMMI Research, SpringerOpen, 2020, 10 (1), pp.2. ⟨10.1186/s13550-019-0587-5⟩
EJNMMI Research, Vol 10, Iss 1, Pp 1-14 (2020)

Purpose Pathological complete response to the neoadjuvant therapy (NAT) for triple negative breast cancer (TNBC) is predictive of prolonged patient survival. Methods for early evaluation of NAT efficiency are still needed, in order to rapidly adjust

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea7b52b99599985ba941aedaeb3da86
https://hal.archives-ouvertes.fr/hal-02489788

Zobrazit plný text záznamu

Phase 0/1 of Positron Emission Tomography (PET) imaging agent [18F]-ODS2004436 as a marker of EGFR mutation in patients with non-small cell lung cancer (NSCLC)

Autor: Yann Bouvet, Jan Hoflack, Jean-Bernard Deloye, Alexandre Cochet, Nicolas Isambert, Philippe Genne, Petra Blom, Charles Coutant, Aurélie Bertaut, Cyril Berthet, Pascal Foucher, Gilles Viot, Jean-Marc Vrigneaud, Bruno Coudert, Pierre Fumoleau

Publikováno v: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2018, Dusseldorf, Germany. pp.S172 / Meeting Abstract: OP-523

e24184Background: Multiple EGFR tyrosine kinase inhibitors (TKIs) are approved for treatment of NSCLC harboring EGFR activating mutations or secondary TKIs resistant mutation. We evaluate a new PET...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f081bd03989db9ea82b5ba11633a5f3
https://u-bourgogne.hal.science/hal-01950923

Zobrazit plný text záznamu

GFR is better estimated by considering both serum cystatin C and creatinine levels

Autor: Stéphane Decramer, Mathieu Tafani, Etienne Chatelut, Yvon Coulais, Sophie Séronie-Vivien, Yann Bouvet, François Bouissou

Publikováno v: Pediatric nephrology (Berlin, Germany). 21(9)

Serum cystatin C (cysC) is a potential marker of the glomerular filtration rate (GFR) that has generated conflicting reports in children. A prospective study was conducted to assess the benefit of considering cysC together with serum creatinine (SCr)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7cc9fb3caf6192f7aedf300c250b855
https://pubmed.ncbi.nlm.nih.gov/16794818

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání